2,2,2-Trifluoroethyl-thiadiazines: a patent evaluation of WO2016023927.

about

2,2,2-Trifluoroethyl-thiadiazines: a patent evaluation of WO2016023927.

Item

http://www.wikidata.org/entity/Q39244962

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

2,2,2-Trifluoroethyl-thiadiazines: a patent evaluation of WO2016023927.

@en

2,2,2-Trifluoroethyl-thiadiazines: a patent evaluation of WO2016023927.

@nl

type

Item

label

2,2,2-Trifluoroethyl-thiadiazines: a patent evaluation of WO2016023927.

@en

2,2,2-Trifluoroethyl-thiadiazines: a patent evaluation of WO2016023927.

@nl

prefLabel

2,2,2-Trifluoroethyl-thiadiazines: a patent evaluation of WO2016023927.

@en

2,2,2-Trifluoroethyl-thiadiazines: a patent evaluation of WO2016023927.

@nl

P1476

2,2,2-Trifluoroethyl-thiadiazines: a patent evaluation of WO2016023927.

@en

P2093

Sergey G Krivokolysko

http://www.w3.org/2001/XMLSchema#string

P2860

The cholinergic hypothesis of Alzheimer's disease: a review of progress

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

Cholinesterase inhibitors for Alzheimer's disease

Ubiquitin phosphorylation in Parkinson's disease: Implications for pathogenesis and treatment

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs

Crystal structure of memapsin 2 (beta-secretase) in complex with an inhibitor OM00-3

Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validation

Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors

Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor That Affords Robust CNS Aβ Reduction

P304

1371-1376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543776.2016.1254193

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elena A Chigorina

Victor V Dotsenko

P577

2016-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27785946

http://www.w3.org/2001/XMLSchema#string